SlideShare a Scribd company logo
1 of 25
Diagnostic and Treatment
Dilemmas in NHL
Archrob Khuhapinant, M.D., Ph.D.
Board of Internal Medicine, Hematology and
Clinical Pathology
Division of Hematology, Faculty of Medicine
Siriraj Hospital, Mahidol University, Thailand
22 February, 2013
A 63-YO Male with Chronic Sinusitis and
Nasal Obstruction
 An elderly male has suffered from chronic
sinusitis and difficult nasal breathing for 18
months.
 Numerous visits to ENT department in many
governmental and private hospital with multiple
episodes of antibiotics and small surgical
debridement
 Multiple CT scan revealed only pansinusitis with
local destruction
 Pathological biopsies revealed only necrosis and
inflammation.
Important Investigations
 Hb 13.1 g/dl, WBC 8710/mm3 (N 90.8, L 6, M
3.2), platelet 272 000/mm3
 Normal renal and liver function test
 LDH 283 U/L
 HBsAg, Anti-HCV, Anti-HIV – negative
 Anti-HBc Ab – positive
 Serum galactomannan - negative
 Initial workup to exclude Wegener
Granulomatosis
 C-ANCA - negative
 P-ANCA – positive
 Anti-Myeloperoxidase (MPO) – negative
 Anti-Proteinase 3 – negative
 Multiple biopsy at left maxillary mucosa, right
inferior turbinate, left ethmoid, left soft palate,
right oropharynx were done
Tissue Biopsy
HE
CD56
Courtesy of T Pongpruttipan, MD.
Final Pathological Diagnosis
 Varying degree of tissue necrosis with focal
abnormal mononuclear aggregations
 Extranodal NK/T-cell lymphoma, nasal type
 CD3+, CD20-, CD56+, CD5-, TIA1+, beta F1-,
CXCL13 focal+, EBER+
 Lymphoma at right maxillary sinus, right
inferior turbinate, left soft palate
 Chronic inflammation at left ethmoid
Diagnosis of Sinonasal Lymphoma
 32 pts, Taichung Veterans
General Hospital, 1990-2010
 Symptoms
 Nasal obstruction
 Rhinorrhea
 Bloody
discharge/epistaxis
 Post nasal drip
 Facial swelling
 Neck mass
 Orbital symptoms
 Fever
 Weight loss
 Time to diagnosis 8.9
months
 First impression
 Benign or malignant
nasal neoplasms 20
(62.5%)
 Rhinitis or rhinosinusitis
12 (37.5%)
 Final diagnosis
 NK/T-cell lymphoma 13
(40.6%)
 PTCL 12 (37.5%)
 DLBCL 7 (21.9%)
 Success diagnosis due to
repeated biopsy, endoscopic
sinus surgery, turbinectomy,
Caldwell-Luc operation
Yen TT, et al. The diagnosis of sinonasal lymphoma: a challenge for
rhinologists. Eur Arch Otorhinolaryngol 2012;269:1463-9.
Diagnostic Dilemma in ENKTL
 Factors relating to
delayed diagnosis
 Insufficient specimen
size
 Massive necrosis
 Large number of
inflammatory cells
 Poor atypia
 Average time delay
12.8 months
 Poor prognostic factors
 Age >60 years
 B symptoms
 ECOG PS ≥ 2
 High LDH
 Tumor spreads to
adjacent lymph nodes
 Tumor spreads to skin
or adjacent bone
 High Ki67
 EBV DNA titer >6.1
x107
copies/ml
Yanagi H, et al. Extranodal natural killer/T-cell
lymphoma: a diagnostic dilemma. Rhinology
2012;50(3):325-31.
Poor Overall Survival for ENKTL
Vose J, et al. International peripheral T-cell and natural killer/T-cell lymphoma
study: pathology findings and clinical outcomes. JCO 2008;26:4124-30.
Outcome of ENKTL Treatment
Status N Treatment CR rate
(%)
OS Reference
New case 47 CHOP 18 5-Y
10%
Ann Oncol
2012;21:1032-40.
Relapsed/
refractory
6 SMILE 50 NA Cancer Sci
2008;99:1016-20.
Relapsed/
refractory
39 SMILE 38 NA JCO 2010;28:584s.
Relapsed/
refractory
18 LMD 56 NA Blood
2008;112:217a.
Relapsed/
refractory
15 L-asp + MTX 47 5-Y
33 %
Ann Oncol
2009;20:110-6.
LOGO
Wichuda Thamprasert, M.D.,
Archrob Khuhapinant,M.D.,Ph.D.
A 7-Year Retrospective Clinical Study of
Patients Diagnosed of Extranodal NK/T-cell
Lymphoma, Nasal Type in Siriraj Hospital
Division of Hematology, Faculty of Medicine,
Siriraj Hospital, Mahidol University,Thailand
Abstract book of the 41th annual conference of the Thai Society of Hematology 2012. Controversies
in Hematology. March 12-15, 2012. Bangkok, Thailand, p116.
Results: Baseline characteristic
Characteristic No. of patients (%)
Age
< 60 y 30 (83.3)
> 60 y 6 (16.7)
Sex
Male 20 (56)
Female 16 (44)
Primary site of tumor
Nasal cavity 22 (61.1)
Sinus 2 (5.6)
Nasopharynx/oropharynx 5 (13.9)
Intestine 2 (5.6)
skin 5 (13.9)
Type of lesion
Mass 24 (66.7)
Infiltrative 7 (19.4)
Ulcerative 5 (13.9)
Characteristic No. of patients (%)
Local invasion
Yes 16 (44.4)
No 19 (52.8)
Bone marrow involvement
Yes 2 (5.7)
No 33 (94.3)
Ann Arbor stage
I ,II 25 (69.4)
III, IV 11 (30.6)
B symptom
Yes 29 (80.6)
No 7 (19.4)
International prognostic
index
0-1 22 (61.1)
2-4 14 (38.9)
Characteristic No. of patients (%)
LDH Level
Normal 18 (52.9)
Elevated 16 (47.1)
Initial EBV DNA status (n=8)
< 6.1 x 107
copies/ml 8 (100)
range < 600- 233,000 copies/ml median of 2,625 copies/ml
Results: Baseline characteristic
Results: Treatment outcome
Firstline treatment outcome (n=31)*
Chemotherapy/RT
No. of
patients(%)
IT
Treatment outcome
CR PR SD PD Death
CHOP
with local RT 4 (12.9) 3 4 - - - -
without local RT 24 (77.4) 17 4 - 1 8 9
SMILE 1 (3.2) - 1 - - - -
CHOEP + local RT 1 (3.2) - 1 - - - -
Cisplatin/5FU 1 (3.2) - - 1 - - -
Total 31 20 10 1 1 8 9
Note * 2 patients cannot be evaluated for treatment outcome due to
ongoing treatment
CR rate 16%
Results: Overall survival
• ENKTL poorly responds to CHOP result in
CR rate only 16 % with short duration of
remission
• Local radiation combine with chemotherapy
resulted in better outcome
• Poor outcome were associated with no
local radiation, local invasion, low serum
albumin ( < 3.5 g/dL), ECOG ≥2, and
elevated serum LDH
Yamaguchi M, et al. JCO 2011;29:4410-16.
A 58-YR Female with Multiple Rectal Polyp
 A middle-aged woman has complaint of
multiple episode of lower abdominal pain and
diarrhea.
 Pharmacologic treatment or changes in
intake food characteristics were fruitless.
 She denied fever, body mass or nodules,
weight loss, malaise or fatigue.
 Stool examination and parasitic examination
were unremarkable.
Esophago-Gastroduodenoscopic Finding
Colonoscopic Finding (1)
Colonoscopic Finding (2)
 Numerous diminutive polyps at rectum
 Biospy was done
 Pathological finding
 Abnormal lymphoid infiltration, consistent with
malignant lymphoma, diffuse large B-cell
lymphoma, NOS
 Diffuse mucosal infiltration by medium and
large-sized lymphoid cells; marked with CD20,
bcl-2 and bcl-6, not marked with CD3
Colonoscopic Finding (3)
Important Investigations
 Hb 15 g/dl, WBC 9400/mm3 (N 56.2, L 40, M
3.1, E 0.5), platelet 231 000/mm3
 Normal renal and liver function tests
 LDH 378 U/L
 CT scan of neck, chest, whole abdomen
 No significant cervical, mediastinal,
intraabdominal lymphadenopathy. No
stomach, intestinal or colonic mass. No
ascites.
Bone Marrow Aspiration
 Numerous small lymphoid cells around 60%
 Very few medium-sized or large lymphoid
cells

More Related Content

What's hot

Eales disease by dr.asmat
Eales disease by dr.asmatEales disease by dr.asmat
Eales disease by dr.asmatjarar66
 
Hodgkin Lymphoma: Latest Concepts
Hodgkin Lymphoma: Latest ConceptsHodgkin Lymphoma: Latest Concepts
Hodgkin Lymphoma: Latest Conceptsspa718
 
The role of propranolol in the treatment of infantile hemangioma
The role of propranolol in the treatment of infantile hemangiomaThe role of propranolol in the treatment of infantile hemangioma
The role of propranolol in the treatment of infantile hemangiomaelisa novi
 
Wound management Association Ireland 2011
Wound management Association Ireland 2011Wound management Association Ireland 2011
Wound management Association Ireland 2011AMNCH Vascular Surgery
 
Leads free trial)
Leads free trial)Leads free trial)
Leads free trial)Iqbal Dar
 
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL)Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL)Subhash Thakur
 
Locoregional therapy for HCC
Locoregional therapy for HCCLocoregional therapy for HCC
Locoregional therapy for HCCPratap Tiwari
 
Hemangioma in hypopharynx in adult patient
Hemangioma in hypopharynx in adult patientHemangioma in hypopharynx in adult patient
Hemangioma in hypopharynx in adult patientLinda Veidere
 
Venous Thromboembolism in the Cancer Patient
Venous Thromboembolism in the Cancer PatientVenous Thromboembolism in the Cancer Patient
Venous Thromboembolism in the Cancer Patientlarriva
 
Wegener's Granulomatosis
Wegener's Granulomatosis  Wegener's Granulomatosis
Wegener's Granulomatosis Ashraf Hefny
 

What's hot (20)

Eales disease by dr.asmat
Eales disease by dr.asmatEales disease by dr.asmat
Eales disease by dr.asmat
 
ANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal DiseasesANCA vasculitis and Renal Diseases
ANCA vasculitis and Renal Diseases
 
Hodgkin Lymphoma: Latest Concepts
Hodgkin Lymphoma: Latest ConceptsHodgkin Lymphoma: Latest Concepts
Hodgkin Lymphoma: Latest Concepts
 
Git j club hbv trt extensions22
Git j club hbv trt extensions22Git j club hbv trt extensions22
Git j club hbv trt extensions22
 
International Journal of Case Reports & Short Reviews
International Journal of Case Reports & Short ReviewsInternational Journal of Case Reports & Short Reviews
International Journal of Case Reports & Short Reviews
 
The role of propranolol in the treatment of infantile hemangioma
The role of propranolol in the treatment of infantile hemangiomaThe role of propranolol in the treatment of infantile hemangioma
The role of propranolol in the treatment of infantile hemangioma
 
Wound management Association Ireland 2011
Wound management Association Ireland 2011Wound management Association Ireland 2011
Wound management Association Ireland 2011
 
Ventriculitis f
Ventriculitis fVentriculitis f
Ventriculitis f
 
Git j club sbb22
Git j club sbb22Git j club sbb22
Git j club sbb22
 
Leads free trial)
Leads free trial)Leads free trial)
Leads free trial)
 
JNSK 05-00163
JNSK 05-00163JNSK 05-00163
JNSK 05-00163
 
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL)Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL)
 
Locoregional therapy for HCC
Locoregional therapy for HCCLocoregional therapy for HCC
Locoregional therapy for HCC
 
Pwpt eales
Pwpt eales Pwpt eales
Pwpt eales
 
Case presentation
Case presentationCase presentation
Case presentation
 
Hemangioma in hypopharynx in adult patient
Hemangioma in hypopharynx in adult patientHemangioma in hypopharynx in adult patient
Hemangioma in hypopharynx in adult patient
 
Venous Thromboembolism in the Cancer Patient
Venous Thromboembolism in the Cancer PatientVenous Thromboembolism in the Cancer Patient
Venous Thromboembolism in the Cancer Patient
 
Austin Journal of Urology
Austin Journal of UrologyAustin Journal of Urology
Austin Journal of Urology
 
Dvt in malignancy pre
Dvt in malignancy preDvt in malignancy pre
Dvt in malignancy pre
 
Wegener's Granulomatosis
Wegener's Granulomatosis  Wegener's Granulomatosis
Wegener's Granulomatosis
 

Similar to DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL-PART 1

Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?spa718
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryShakila Rifat
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryShakila Rifat
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryShakila Rifat
 
Hodgkin’S And Non Hodgkin’S Lymphoma
Hodgkin’S And Non Hodgkin’S LymphomaHodgkin’S And Non Hodgkin’S Lymphoma
Hodgkin’S And Non Hodgkin’S Lymphomafondas vakalis
 
Conjunctival MALT Lymphoma
Conjunctival MALT LymphomaConjunctival MALT Lymphoma
Conjunctival MALT LymphomaRyan Alfonso
 
Renal cell carcinoma. 2015
Renal cell carcinoma. 2015Renal cell carcinoma. 2015
Renal cell carcinoma. 2015Montse Carrere
 
Evaluation the outcomes of partial laryngectomy .pptx
Evaluation the outcomes of partial laryngectomy .pptxEvaluation the outcomes of partial laryngectomy .pptx
Evaluation the outcomes of partial laryngectomy .pptxssuserbc95ff
 
Crespi, there are conflicting data about efficacy of colonoscopy
Crespi, there are conflicting data about efficacy of colonoscopy Crespi, there are conflicting data about efficacy of colonoscopy
Crespi, there are conflicting data about efficacy of colonoscopy Gianfranco Tammaro
 
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2Maarten Naesens
 
CA CERVIX hhhhghg approach to patient h ca
CA CERVIX hhhhghg approach to patient h caCA CERVIX hhhhghg approach to patient h ca
CA CERVIX hhhhghg approach to patient h caDavidKamau27
 
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2 Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2 Dr. Aryan (Anish Dhakal)
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinomaspa718
 
Management of Primary CNS Lymphoma (PCNSL)
Management of Primary CNS Lymphoma (PCNSL)Management of Primary CNS Lymphoma (PCNSL)
Management of Primary CNS Lymphoma (PCNSL)Narayan Adhikari
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Mohamed Abdulla
 
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancer
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancerRare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancer
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancerEuropean School of Oncology
 
Ca. gástrico metastásico inmunoterapia
Ca. gástrico metastásico inmunoterapiaCa. gástrico metastásico inmunoterapia
Ca. gástrico metastásico inmunoterapiaUACH, Valdivia
 

Similar to DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL-PART 1 (20)

R.marmo l. l'enteroscopia
R.marmo l. l'enteroscopiaR.marmo l. l'enteroscopia
R.marmo l. l'enteroscopia
 
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
Ideal induction therapy for newly diagnosed AML. Do we have a consensus?
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhury
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhury
 
Adrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhuryAdrenal ca dr.sharfuddin chowdhury
Adrenal ca dr.sharfuddin chowdhury
 
Hodgkin’S And Non Hodgkin’S Lymphoma
Hodgkin’S And Non Hodgkin’S LymphomaHodgkin’S And Non Hodgkin’S Lymphoma
Hodgkin’S And Non Hodgkin’S Lymphoma
 
Conjunctival MALT Lymphoma
Conjunctival MALT LymphomaConjunctival MALT Lymphoma
Conjunctival MALT Lymphoma
 
Renal cell carcinoma. 2015
Renal cell carcinoma. 2015Renal cell carcinoma. 2015
Renal cell carcinoma. 2015
 
Evaluation the outcomes of partial laryngectomy .pptx
Evaluation the outcomes of partial laryngectomy .pptxEvaluation the outcomes of partial laryngectomy .pptx
Evaluation the outcomes of partial laryngectomy .pptx
 
Crespi, there are conflicting data about efficacy of colonoscopy
Crespi, there are conflicting data about efficacy of colonoscopy Crespi, there are conflicting data about efficacy of colonoscopy
Crespi, there are conflicting data about efficacy of colonoscopy
 
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
ESOT barcelona - histological endpoints in kidney transplantation ultrashort-2
 
CA CERVIX hhhhghg approach to patient h ca
CA CERVIX hhhhghg approach to patient h caCA CERVIX hhhhghg approach to patient h ca
CA CERVIX hhhhghg approach to patient h ca
 
Journal club
Journal clubJournal club
Journal club
 
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2 Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
Journal Club: Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia 2
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinoma
 
Management of Primary CNS Lymphoma (PCNSL)
Management of Primary CNS Lymphoma (PCNSL)Management of Primary CNS Lymphoma (PCNSL)
Management of Primary CNS Lymphoma (PCNSL)
 
Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015Neuroendocrine tumors in 2015
Neuroendocrine tumors in 2015
 
Eds 16 10
Eds 16 10Eds 16 10
Eds 16 10
 
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancer
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancerRare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancer
Rare Solid Cancers: An Introduction - Slide 7 - A. Berruti - Adrenal cancer
 
Ca. gástrico metastásico inmunoterapia
Ca. gástrico metastásico inmunoterapiaCa. gástrico metastásico inmunoterapia
Ca. gástrico metastásico inmunoterapia
 

More from spa718

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotaispa718
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery spa718
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancerspa718
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancerspa718
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerspa718
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinomaspa718
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancerspa718
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancerspa718
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancerspa718
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancerspa718
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancerspa718
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancerspa718
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancerspa718
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015spa718
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancerspa718
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHDspa718
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myelomaspa718
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapyspa718
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapyspa718
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Updatespa718
 

More from spa718 (20)

1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai1600 1620 siwanon jirawatnotai
1600 1620 siwanon jirawatnotai
 
Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery Controversies in hepato-biliary surgery
Controversies in hepato-biliary surgery
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
Pancreatic Cancer
Pancreatic CancerPancreatic Cancer
Pancreatic Cancer
 
Chemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancerChemoradiation vs Surgery for rectal cancer
Chemoradiation vs Surgery for rectal cancer
 
Cholangiocarcinoma
CholangiocarcinomaCholangiocarcinoma
Cholangiocarcinoma
 
Immunotherapy for Colorectal Cancer
Immunotherapy for Colorectal CancerImmunotherapy for Colorectal Cancer
Immunotherapy for Colorectal Cancer
 
Surgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung CancerSurgical Approach to Non Small Cell Lung Cancer
Surgical Approach to Non Small Cell Lung Cancer
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Update on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast CancerUpdate on Management of Triple Negative Breast Cancer
Update on Management of Triple Negative Breast Cancer
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancer
 
Controversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast CancerControversies in Surgical Approach to Breast Cancer
Controversies in Surgical Approach to Breast Cancer
 
ImmunoOncology in Lung Cancer
ImmunoOncology in Lung CancerImmunoOncology in Lung Cancer
ImmunoOncology in Lung Cancer
 
Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015Breast Cancer Highlights: ASCO 2015
Breast Cancer Highlights: ASCO 2015
 
Updates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast CancerUpdates in Radiotherapy for Breast Cancer
Updates in Radiotherapy for Breast Cancer
 
Regulatory T Cells and GVHD
Regulatory T Cells and GVHDRegulatory T Cells and GVHD
Regulatory T Cells and GVHD
 
Immunotherapy for Multiple Myeloma
Immunotherapy for Multiple MyelomaImmunotherapy for Multiple Myeloma
Immunotherapy for Multiple Myeloma
 
NHL immunotherapy
NHL immunotherapyNHL immunotherapy
NHL immunotherapy
 
AML and Cell Therapy
AML and Cell TherapyAML and Cell Therapy
AML and Cell Therapy
 
Acute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment UpdateAcute Lymphoblastic Lymphoma: Treatment Update
Acute Lymphoblastic Lymphoma: Treatment Update
 

Recently uploaded

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonJericReyAuditor
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 

Recently uploaded (20)

Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Science lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lessonScience lesson Moon for 4th quarter lesson
Science lesson Moon for 4th quarter lesson
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 

DIAGNOSTIC AND TREATMENT DILEMMAS IN NHL-PART 1

  • 1. Diagnostic and Treatment Dilemmas in NHL Archrob Khuhapinant, M.D., Ph.D. Board of Internal Medicine, Hematology and Clinical Pathology Division of Hematology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand 22 February, 2013
  • 2. A 63-YO Male with Chronic Sinusitis and Nasal Obstruction  An elderly male has suffered from chronic sinusitis and difficult nasal breathing for 18 months.  Numerous visits to ENT department in many governmental and private hospital with multiple episodes of antibiotics and small surgical debridement  Multiple CT scan revealed only pansinusitis with local destruction  Pathological biopsies revealed only necrosis and inflammation.
  • 3.
  • 4. Important Investigations  Hb 13.1 g/dl, WBC 8710/mm3 (N 90.8, L 6, M 3.2), platelet 272 000/mm3  Normal renal and liver function test  LDH 283 U/L  HBsAg, Anti-HCV, Anti-HIV – negative  Anti-HBc Ab – positive  Serum galactomannan - negative
  • 5.  Initial workup to exclude Wegener Granulomatosis  C-ANCA - negative  P-ANCA – positive  Anti-Myeloperoxidase (MPO) – negative  Anti-Proteinase 3 – negative  Multiple biopsy at left maxillary mucosa, right inferior turbinate, left ethmoid, left soft palate, right oropharynx were done
  • 6. Tissue Biopsy HE CD56 Courtesy of T Pongpruttipan, MD.
  • 7. Final Pathological Diagnosis  Varying degree of tissue necrosis with focal abnormal mononuclear aggregations  Extranodal NK/T-cell lymphoma, nasal type  CD3+, CD20-, CD56+, CD5-, TIA1+, beta F1-, CXCL13 focal+, EBER+  Lymphoma at right maxillary sinus, right inferior turbinate, left soft palate  Chronic inflammation at left ethmoid
  • 8. Diagnosis of Sinonasal Lymphoma  32 pts, Taichung Veterans General Hospital, 1990-2010  Symptoms  Nasal obstruction  Rhinorrhea  Bloody discharge/epistaxis  Post nasal drip  Facial swelling  Neck mass  Orbital symptoms  Fever  Weight loss  Time to diagnosis 8.9 months  First impression  Benign or malignant nasal neoplasms 20 (62.5%)  Rhinitis or rhinosinusitis 12 (37.5%)  Final diagnosis  NK/T-cell lymphoma 13 (40.6%)  PTCL 12 (37.5%)  DLBCL 7 (21.9%)  Success diagnosis due to repeated biopsy, endoscopic sinus surgery, turbinectomy, Caldwell-Luc operation Yen TT, et al. The diagnosis of sinonasal lymphoma: a challenge for rhinologists. Eur Arch Otorhinolaryngol 2012;269:1463-9.
  • 9. Diagnostic Dilemma in ENKTL  Factors relating to delayed diagnosis  Insufficient specimen size  Massive necrosis  Large number of inflammatory cells  Poor atypia  Average time delay 12.8 months  Poor prognostic factors  Age >60 years  B symptoms  ECOG PS ≥ 2  High LDH  Tumor spreads to adjacent lymph nodes  Tumor spreads to skin or adjacent bone  High Ki67  EBV DNA titer >6.1 x107 copies/ml Yanagi H, et al. Extranodal natural killer/T-cell lymphoma: a diagnostic dilemma. Rhinology 2012;50(3):325-31.
  • 10. Poor Overall Survival for ENKTL Vose J, et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. JCO 2008;26:4124-30.
  • 11. Outcome of ENKTL Treatment Status N Treatment CR rate (%) OS Reference New case 47 CHOP 18 5-Y 10% Ann Oncol 2012;21:1032-40. Relapsed/ refractory 6 SMILE 50 NA Cancer Sci 2008;99:1016-20. Relapsed/ refractory 39 SMILE 38 NA JCO 2010;28:584s. Relapsed/ refractory 18 LMD 56 NA Blood 2008;112:217a. Relapsed/ refractory 15 L-asp + MTX 47 5-Y 33 % Ann Oncol 2009;20:110-6.
  • 12. LOGO Wichuda Thamprasert, M.D., Archrob Khuhapinant,M.D.,Ph.D. A 7-Year Retrospective Clinical Study of Patients Diagnosed of Extranodal NK/T-cell Lymphoma, Nasal Type in Siriraj Hospital Division of Hematology, Faculty of Medicine, Siriraj Hospital, Mahidol University,Thailand Abstract book of the 41th annual conference of the Thai Society of Hematology 2012. Controversies in Hematology. March 12-15, 2012. Bangkok, Thailand, p116.
  • 13. Results: Baseline characteristic Characteristic No. of patients (%) Age < 60 y 30 (83.3) > 60 y 6 (16.7) Sex Male 20 (56) Female 16 (44) Primary site of tumor Nasal cavity 22 (61.1) Sinus 2 (5.6) Nasopharynx/oropharynx 5 (13.9) Intestine 2 (5.6) skin 5 (13.9) Type of lesion Mass 24 (66.7) Infiltrative 7 (19.4) Ulcerative 5 (13.9) Characteristic No. of patients (%) Local invasion Yes 16 (44.4) No 19 (52.8) Bone marrow involvement Yes 2 (5.7) No 33 (94.3) Ann Arbor stage I ,II 25 (69.4) III, IV 11 (30.6) B symptom Yes 29 (80.6) No 7 (19.4) International prognostic index 0-1 22 (61.1) 2-4 14 (38.9)
  • 14. Characteristic No. of patients (%) LDH Level Normal 18 (52.9) Elevated 16 (47.1) Initial EBV DNA status (n=8) < 6.1 x 107 copies/ml 8 (100) range < 600- 233,000 copies/ml median of 2,625 copies/ml Results: Baseline characteristic
  • 15. Results: Treatment outcome Firstline treatment outcome (n=31)* Chemotherapy/RT No. of patients(%) IT Treatment outcome CR PR SD PD Death CHOP with local RT 4 (12.9) 3 4 - - - - without local RT 24 (77.4) 17 4 - 1 8 9 SMILE 1 (3.2) - 1 - - - - CHOEP + local RT 1 (3.2) - 1 - - - - Cisplatin/5FU 1 (3.2) - - 1 - - - Total 31 20 10 1 1 8 9 Note * 2 patients cannot be evaluated for treatment outcome due to ongoing treatment CR rate 16%
  • 17. • ENKTL poorly responds to CHOP result in CR rate only 16 % with short duration of remission • Local radiation combine with chemotherapy resulted in better outcome • Poor outcome were associated with no local radiation, local invasion, low serum albumin ( < 3.5 g/dL), ECOG ≥2, and elevated serum LDH
  • 18. Yamaguchi M, et al. JCO 2011;29:4410-16.
  • 19. A 58-YR Female with Multiple Rectal Polyp  A middle-aged woman has complaint of multiple episode of lower abdominal pain and diarrhea.  Pharmacologic treatment or changes in intake food characteristics were fruitless.  She denied fever, body mass or nodules, weight loss, malaise or fatigue.  Stool examination and parasitic examination were unremarkable.
  • 23.  Numerous diminutive polyps at rectum  Biospy was done  Pathological finding  Abnormal lymphoid infiltration, consistent with malignant lymphoma, diffuse large B-cell lymphoma, NOS  Diffuse mucosal infiltration by medium and large-sized lymphoid cells; marked with CD20, bcl-2 and bcl-6, not marked with CD3 Colonoscopic Finding (3)
  • 24. Important Investigations  Hb 15 g/dl, WBC 9400/mm3 (N 56.2, L 40, M 3.1, E 0.5), platelet 231 000/mm3  Normal renal and liver function tests  LDH 378 U/L  CT scan of neck, chest, whole abdomen  No significant cervical, mediastinal, intraabdominal lymphadenopathy. No stomach, intestinal or colonic mass. No ascites.
  • 25. Bone Marrow Aspiration  Numerous small lymphoid cells around 60%  Very few medium-sized or large lymphoid cells

Editor's Notes

  1. HN 51-229275
  2. CT PNS and neck -Absent of nasal septum, all nasal turbinates and superior part of medial wall of left maxillary sinus, likely due to previous surgery. Ill-defined hard palate with small air bubbles in the adjacent soft tissue is noted. -After contrast, a small homogeneous enhancing lesion just beneath the hard palate  residual tumor -Mucoperiosteal thickening of bilateral maxillary and ethmoid sinuses are seen. Fluid in bilateral ethmoid and right frontal sinus is noted. Bilateral nasopharynx appears normal. Intersphenoid septum inserts at midline. Fluid in bilateral mastoid air cells are present. Cavernous sinuses appear normal. Both eyes globes are normal in size and have equal density. No infiltration of retrobulbar fat is seen. The visible brain parenchyma shows no abnromal enhancing lesion. No filling defect in the visible venous sinuses is seen. -A small subcentimeter left jugular node (0.8 cm in long axis) and right posterior cervical posterior cervical (0.6 cm in long axis) are demonstrated. No significant lymphadenopathy is shown. -The visible lung apex shows minimal fibrosis at bilateral apical lung and a tiny calcified subpleural nodule at posterior segment of RUL. No pleural effusion is visualized. IMP: Absent of nasal septum, all nasal turbinates and superior part of medial wall of left maxillary sinus; likely due to previous surgery. suspected residual tumor just beneath the hard palate hard palate destruction, bilateratl maxillary, ethmoid and left frontal sinusitis bilateral mastoiditis a tiny calcifed subpleural nodule at posterior segment of RUL; probably a calcified granuloma